Status:
COMPLETED
Fetal 3D Study (Fetal Body Composition and Volumes Study)
Lead Sponsor:
Katherine Grantz
Collaborating Sponsors:
Baylor College of Medicine
Conditions:
Fetal Growth Restriction
Fetal Growth Abnormality
Eligibility:
FEMALE
18-45 years
Brief Summary
Normal fetal growth is a critical component for a healthy pregnancy and for ensuring the health and well-being of infants throughout childhood and adolescence. One promising area of research suggests ...
Detailed Description
The NICHD Fetal Growth Study was a multi-site, prospective cohort study designed to establish a standard for normal fetal growth (velocity) and size for gestational age in the U.S. population. For the...
Eligibility Criteria
Inclusion
- Women with ultrasound data collected from the NICHD Fetal Growth Studies-Singletons and Twin Gestations
Exclusion
- None
Key Trial Info
Start Date :
April 27 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2019
Estimated Enrollment :
2809 Patients enrolled
Trial Details
Trial ID
NCT03266198
Start Date
April 27 2016
End Date
September 15 2019
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States